What do we know about tailoring treatment with tenofovir?

Andrea CALCAGNO; Giovanni DI PERRI; Stefano BONORA

doi:10.2217/pgs-2016-0003

What do we know about tailoring treatment with tenofovir?

Andrea CALCAGNO
, Giovanni DI PERRI
, Stefano BONORA

Department of Translational Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	531-534
Number of pages	4
Journal	Pharmacogenomics
Volume	17
Issue number	6
DOIs	https://doi.org/10.2217/pgs-2016-0003
Publication status	Published - 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

HIV
pharmacogenetics
pharmacokinetics
renal
tenofovir
toxicity
tubular
Pharmacology
Genetics
Molecular Medicine

Access to Document

10.2217/pgs-2016-0003

https://hdl.handle.net/11579/217000

Cite this

@article{9c1eb21b1b444bb7b66d8699a79f5a0b,

title = "What do we know about tailoring treatment with tenofovir?",

keywords = "HIV, pharmacogenetics, pharmacokinetics, renal, tenofovir, toxicity, tubular, Pharmacology, Genetics, Molecular Medicine, HIV, pharmacogenetics, pharmacokinetics, renal, tenofovir, toxicity, tubular, Pharmacology, Genetics, Molecular Medicine",

author = "Andrea CALCAGNO and \{DI PERRI\}, Giovanni and Stefano BONORA",

year = "2016",

doi = "10.2217/pgs-2016-0003",

language = "English",

volume = "17",

pages = "531--534",

journal = "Pharmacogenomics",

issn = "1462-2416",